Precision over scale
Sub-regional ancestry where the data supports it. Terminal-SNP haplogroups when coverage allows. Confidence tiers when it doesn't. We'd rather show fewer answers honestly than every answer half-right.
No false certaintyNexoGENO OÜ is a genetics and genealogy company built in Estonia. We design the analysis platform we always wished existed — precise enough to hold up under a geneticist's eye, calibrated so you always know what the data says and what it doesn't, and quiet enough to actually enjoy using.
We started NexoGENO because the existing genetics tooling kept breaking the same promise. Big consumer tests stop at vague continental labels. Power-user tools live across half a dozen incompatible programs that drift out of sync every six months. The honest, in-depth analysis people actually wanted was always one rigged-up Excel workflow away.
What everyone we worked with seemed to want was the same thing nobody was actually building: a single workspace that held up at the population level and at the terminal-SNP level, on the same screen, with a workflow you don't have to apologise for. So we built it.
"We aren't trying to be the cheapest. We're trying to be the one you don't have to second-guess." — Founding principle
Estonia is where the company is registered. Not because we're from there — we're a European team — but because the country runs the kind of digital-first incorporation and EU-jurisdiction framework that makes a serious genetics platform straightforward to build the right way. The legal base sits in Tallinn; the work happens wherever the team is.
We're young. We're independently held. We have no obligation to monetise your DNA in a thousand silent ways, and we don't intend to. The whole company is built around one practical rule: your file is yours, your conclusions are earned, and what you see on screen is what your data actually supports.
Every product we ship is judged against these three. If it loses precision to look prettier, ships a result that's quietly broken instead of pausing to tell you, or grows past what the user actually needed — it doesn't ship.
Sub-regional ancestry where the data supports it. Terminal-SNP haplogroups when coverage allows. Confidence tiers when it doesn't. We'd rather show fewer answers honestly than every answer half-right.
No false certaintyIf your DNA file has coverage gaps, formatting issues, or anything else that would make a particular report unreliable, you hear about it from us directly by email. No silent failures, no broken result quietly delivered as if it were fine. The default is to stop, contact you, and sort it out.
We pause, never pretendYour raw file isn't sold, syndicated, or quietly fed into someone else's training set. Every kit profile is yours to delete, end-to-end, on demand. EU-resident data, GDPR handled by default — not as a setting you have to find.
Yours to delete, alwaysWe sell finished reports for people who want a clean, considered answer — and a workspace subscription for people who want to do the analysis themselves. Different audiences, different depths, all reading from the same DNA upload.
Continental breakdowns that resolve to specific regions and valleys when the data supports it. Best-fit ancient mixtures from 3,820+ archaeogenetic samples tied to named civilizations and dated layers — not modern populations relabelled "ancient." Both reads from the same upload.
Y-DNA and mtDNA haplogroups bundled in at terminal-SNP depth where coverage allows. Confidence tiers when it doesn't. No surprise add-ons.
Every report you receive is produced by NexoGENO's own analytical pipeline — our proprietary modelling engines, our scoring methods, our internal reference architecture. The science isn't borrowed and isn't outsourced. The accuracy of any genetic conclusion is ultimately bounded by the quality and breadth of the data underneath, and we own that layer end-to-end.
And the database doesn't sit still. New reference populations, new ancient sample releases from peer-reviewed publications, recalibration as the field moves. Every conclusion you see is the most accurate read we can produce against the data we have today — and gets sharper as the database keeps widening.
Selected pharmacogenetic, trait, and carrier markers — sourced, confidence-rated, presented in plain language with population context. Educational, never diagnostic. We tell you what the markers say and what the literature says about them, then leave the medical conversations to your doctor.
For deeper work — full PRS pipelines, monogenic screening, longevity factors — Health Studio is the dedicated subscription.
We're a young company with a long roadmap. Some of it is shipped, some of it is in the workshop, some of it is honestly aspirational. Here it is in plain English so you can hold us to it.
One-time reports for Modern Ancestry (with Y/mtDNA) and Ancient DNA Ancestry are live. Studio v1 covers coordinate generation, target modelling, distance scoring, and kit matching with chromosome-level overlays.
Multi-method Y-DNA + mtDNA calling on every consumer file format, VCF, and FASTA. Marker-level evidence, deep-clade hints, conflict warnings when methods disagree.
Full PRS pipelines, monogenic screening, longevity factors — packaged for serious health-context research. The family-tree builder ties kits, matches, and historical records into a single browsable graph.
Beyond reports: a sovereign, EU-resident analysis backend other clinics, researchers, and genealogy practitioners can build on. Same precision, same transparency, exposed via API.
We intend to keep widening the platform — more reference populations across every continent, more ancient sample releases, more linked tools — until "precision ancestry" means the same depth of analysis whether you're from Lisbon, Lagos, Lima or Lahore. Every region, every lineage, the same standard.
NexoGENO OÜ is incorporated in Estonia, operates under EU law, and runs entirely on EU-resident infrastructure. We pay our taxes there, we host our data there, and we'll respond to legal process the same way any serious European company does.
We're independently held. There are no growth-at-all-costs investors steering the roadmap. The pace is set by what actually ships well — not by quarterly reporting cycles.
If you want to partner, integrate, license a panel, or work with us, the inbox is below.
One upload. Lifetime access. No subscription required to start.